{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:33:33Z","timestamp":1778686413486,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1124\/jpet.107.125526","type":"journal-article","created":{"date-parts":[[2007,9,14]],"date-time":"2007-09-14T00:38:58Z","timestamp":1189730338000},"page":"899-906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["ST91 [2-(2,6-Diethylphenylamino)-2-imidazoline Hydrochloride]-Mediated Spinal Antinociception and Synergy with Opioids Persists in the Absence of Functional \u03b1-2A- or \u03b1-2C-Adrenergic Receptors"],"prefix":"10.1016","volume":"323","author":[{"given":"Laura S.","family":"Stone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelley F.","family":"Kitto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Eisenach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn A.","family":"Fairbanks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George L.","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.107.125526_bib1","doi-asserted-by":"crossref","unstructured":"Alguacil LF and Morales L (2004) Alpha-2 adrenoceptor ligands and opioid drugs: pharmacological interactions of therapeutic interest. Curr Neuropharmacol 2: 343\u2013352.","DOI":"10.2174\/1570159043359512"},{"key":"10.1124\/jpet.107.125526_bib2","doi-asserted-by":"crossref","unstructured":"Alhaider AA and Wilcox GL (1993) Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice. J Pharmacol Exp Ther 265: 378\u2013385.","DOI":"10.1016\/S0022-3565(25)38088-2"},{"key":"10.1124\/jpet.107.125526_bib3","doi-asserted-by":"crossref","unstructured":"Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RJ, and Trendelenburg U (1994) International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46: 121\u2013136.","DOI":"10.1016\/S0031-6997(25)06780-8"},{"key":"10.1124\/jpet.107.125526_bib4","doi-asserted-by":"crossref","unstructured":"Dowlatshahi P and Yaksh TL (1997) Differential effects of two intraventricularly injected alpha 2 agonists, ST-91 and dexmedetomidine, on electroencephalogram, feeding, and electromyogram. Anesth Analg 84: 133\u2013138.","DOI":"10.1097\/00000539-199701000-00025"},{"key":"10.1124\/jpet.107.125526_bib5","doi-asserted-by":"crossref","unstructured":"Duflo F, Li X, Bantel C, Pancaro C, Vincler M, and Eisenach JC (2002) Peripheral nerve injury alters the alpha2 adrenoceptor subtype activated by clonidine for analgesia. Anesthesiology 97: 636\u2013641.","DOI":"10.1097\/00000542-200209000-00018"},{"key":"10.1124\/jpet.107.125526_bib6","doi-asserted-by":"crossref","unstructured":"Fairbanks CA, Stone LS, Kitto KF, Nguyen HO, Posthumus IJ, and Wilcox GL (2002) alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. J Pharmacol Exp Ther 300: 282\u2013290.","DOI":"10.1124\/jpet.300.1.282"},{"key":"10.1124\/jpet.107.125526_bib7","doi-asserted-by":"crossref","unstructured":"Fairbanks CA and Wilcox GL (1999) Moxonidine, a selective alpha2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice. J Pharmacol Exp Ther 290: 403\u2013412.","DOI":"10.1016\/S0022-3565(24)34914-6"},{"key":"10.1124\/jpet.107.125526_bib8","doi-asserted-by":"crossref","unstructured":"Gold MS, Dastmalchi S, and Levine JD (1997) Alpha 2 adrenergic receptor subtypes in rat dorsal root and superior cervical ganglion neurons. Pain 69: 179\u2013190.","DOI":"10.1016\/S0304-3959(96)03218-6"},{"key":"10.1124\/jpet.107.125526_bib9","doi-asserted-by":"crossref","unstructured":"Graham BA, Hammond DL, and Proudfit HK (2000) Synergistic interactions between two alpha(2)-adrenoceptor agonists, dexmedetomidine and ST-91, in two substrains of Sprague-Dawley rats. Pain 85: 135\u2013143.","DOI":"10.1016\/S0304-3959(99)00261-4"},{"key":"10.1124\/jpet.107.125526_bib10","doi-asserted-by":"crossref","unstructured":"Hieble JP, DeMarinis RM, Fowler PJ, and Matthews WD (1986) Selective alpha-2 adrenoceptor blockade by SK&F 86466: in vitro characterization of receptor selectivity. J Pharmacol Exp Ther 236: 90\u201396.","DOI":"10.1016\/S0022-3565(25)38784-7"},{"key":"10.1124\/jpet.107.125526_bib11","unstructured":"Hoefke W, Kobinger W, and Walland A (1975) Relationship between activity and structure in derivatives of clonidine. Arzneimittelforschung 25: 786\u2013793."},{"key":"10.1124\/jpet.107.125526_bib12","doi-asserted-by":"crossref","unstructured":"Hunter JC, Fontana DJ, Hedley LR, Jasper JR, Lewis R, Link RE, Secchi R, Sutton J, and Eglen RM (1997) Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br J Pharmacol 122: 1339\u20131344.","DOI":"10.1038\/sj.bjp.0701520"},{"key":"10.1124\/jpet.107.125526_bib13","doi-asserted-by":"crossref","unstructured":"Hylden JL and Wilcox GL (1981) Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice. Brain Res 217: 212\u2013215.","DOI":"10.1016\/0006-8993(81)90203-1"},{"key":"10.1124\/jpet.107.125526_bib14","doi-asserted-by":"crossref","unstructured":"Hylden JLK and Wilcox GL (1980) Intrathecal morphine in mice: a new technique. Eur J Pharmacol 67: 313\u2013316.","DOI":"10.1016\/0014-2999(80)90515-4"},{"key":"10.1124\/jpet.107.125526_bib15","doi-asserted-by":"crossref","unstructured":"Jasper JR, Lesnick JD, Chang LK, Yamanishi SS, Chang TK, Hsu SA, Daunt DA, Bonhaus DW, and Eglen RM (1998) Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS binding. Biochem Pharmacol 55: 1035\u20131043.","DOI":"10.1016\/S0006-2952(97)00631-X"},{"key":"10.1124\/jpet.107.125526_bib16","doi-asserted-by":"crossref","unstructured":"Kaalzow L (1974) Analgesia produced by clonidine in mice and rats. J Pharm Pharmacol 26: 361.","DOI":"10.1111\/j.2042-7158.1974.tb09291.x"},{"key":"10.1124\/jpet.107.125526_bib17","doi-asserted-by":"crossref","unstructured":"Kable JW, Murrin LC, and Bylund DB (2000) In vivo gene modification elucidates subtype-specific functions of alpha(2)-adrenergic receptors. J Pharmacol Exp Ther 293: 1\u20137.","DOI":"10.1016\/S0022-3565(24)39196-7"},{"key":"10.1124\/jpet.107.125526_bib18","doi-asserted-by":"crossref","unstructured":"Kobinger W and Pichler L (1975) Investigation into some imidazoline compounds, with respect to peripheral alpha-adrenoceptor stimulation and depression of cardiovascular centers. Naunyn Schmiedebergs Arch Pharmacol 291: 175\u2013191.","DOI":"10.1007\/BF00500048"},{"key":"10.1124\/jpet.107.125526_bib19","doi-asserted-by":"crossref","unstructured":"Lakhlani PP, Macmillan LB, Guo TZ, Mccool BA, Lovinger DM, Maze M, and Limbird LE (1997) Substitution of a mutant alpha(2a)-adrenergic receptor via hit and run gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc Natl Acad Sci U S A 94: 9950\u20139955.","DOI":"10.1073\/pnas.94.18.9950"},{"key":"10.1124\/jpet.107.125526_bib20","doi-asserted-by":"crossref","unstructured":"Link RE, Stevens MS, Kulatunga M, Scheinin M, Barsh GS, and Kobilka BK (1995) Targeted inactivation of the gene encoding the mouse alpha 2c-adrenoceptor homolog. Mol Pharmacol 48: 48\u201355.","DOI":"10.1016\/S0026-895X(25)10044-8"},{"key":"10.1124\/jpet.107.125526_bib21","doi-asserted-by":"crossref","unstructured":"MacMillan LB, Hein L, Smith MS, Piascik MT, and Limbird LE (1996) Central hypotensive effects of the alpha2a-adrenergic receptor subtype. Science 273: 801\u2013803.","DOI":"10.1126\/science.273.5276.801"},{"key":"10.1124\/jpet.107.125526_bib22","doi-asserted-by":"crossref","unstructured":"Meana JJ, Callado LF, Pazos A, Grijalba B, and Garcia-Sevilla JA (1996) The subtype-selective alpha 2-adrenoceptor antagonists BRL 44408 and ARC 239 also recognize 5-HT1A receptors in the rat brain. Eur J Pharmacol 312: 385\u2013388.","DOI":"10.1016\/0014-2999(96)00598-5"},{"key":"10.1124\/jpet.107.125526_bib23","doi-asserted-by":"crossref","unstructured":"Monasky MS, Zinsmeister AR, Stevens CW, and Yaksh TL (1990) Interaction of intrathecal morphine and ST-91 on antinociception in the rat: dose-response analysis, antagonism and clearance. J Pharmacol Exp Ther 254: 383\u2013392.","DOI":"10.1016\/S0022-3565(25)12633-5"},{"key":"10.1124\/jpet.107.125526_bib24","doi-asserted-by":"crossref","unstructured":"Nagasaka H and Yaksh TL (1990) Pharmacology of intrathecal adrenergic agonists: cardiovascular and nociceptive reflexes in halothane-anesthetized rats. Anesthesiology 73: 1198\u20131207.","DOI":"10.1097\/00000542-199012000-00018"},{"key":"10.1124\/jpet.107.125526_bib25","doi-asserted-by":"crossref","unstructured":"Newman-Tancredi A, Nicolas JP, Audinot V, Gavaudan S, Verriele L, Touzard M, Chaput C, Richard N, and Millan MJ (1998) Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 358: 197\u2013206.","DOI":"10.1007\/PL00005243"},{"key":"10.1124\/jpet.107.125526_bib26","doi-asserted-by":"crossref","unstructured":"Nicholas AP, Pieribone V, and Hokfelt T (1993) Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J Comp Neurol 328: 575\u2013594.","DOI":"10.1002\/cne.903280409"},{"key":"10.1124\/jpet.107.125526_bib27","doi-asserted-by":"crossref","unstructured":"Sawamura S, Kingery WS, Davies MF, Agashe GS, Clark JD, Kobilka BK, Hashimoto T, and Maze M (2000) Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of \u03b12B adrenoceptors. J Neurosci 20: 9242\u20139251.","DOI":"10.1523\/JNEUROSCI.20-24-09242.2000"},{"key":"10.1124\/jpet.107.125526_bib28","doi-asserted-by":"crossref","unstructured":"Scheinin M, Lomasney JW, Hayden HD, Schambra UB, Caron MG, Lefkowitz RJ, and Fremeau RJ (1994) Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain. Brain Res Mol Brain Res 21: 133\u2013149.","DOI":"10.1016\/0169-328X(94)90386-7"},{"key":"10.1124\/jpet.107.125526_bib29","doi-asserted-by":"crossref","unstructured":"Shi TS, Winzer-Serhan U, Leslie F, and Hokfelt T (2000) Distribution and regulation of alpha(2)-adrenoceptors in rat dorsal root ganglia. Pain 84: 319\u2013330.","DOI":"10.1016\/S0304-3959(99)00224-9"},{"key":"10.1124\/jpet.107.125526_bib30","doi-asserted-by":"crossref","unstructured":"Stone LS, MacMillan LB, Kitto KF, Limbird LE, and Wilcox GL (1997) The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy. J Neurosci 17: 7157\u20137165.","DOI":"10.1523\/JNEUROSCI.17-18-07157.1997"},{"key":"10.1124\/jpet.107.125526_bib31","doi-asserted-by":"crossref","unstructured":"Takano Y, Takano M, and Yaksh TL (1992) The effect of intrathecally administered imiloxan and WB4101: possible role of alpha 2-adrenoceptor subtypes in the spinal cord. Eur J Pharmacol 219: 465\u2013468.","DOI":"10.1016\/0014-2999(92)90490-U"},{"key":"10.1124\/jpet.107.125526_bib32","doi-asserted-by":"crossref","unstructured":"Takano Y and Yaksh TL (1992) Characterization of the pharmacology of intrathecally administered alpha-2 agonists and antagonists in rats. J Pharmacol Exp Ther 261: 764\u2013772.","DOI":"10.1016\/S0022-3565(25)11102-6"},{"key":"10.1124\/jpet.107.125526_bib33","doi-asserted-by":"crossref","unstructured":"Takano Y and Yaksh TL (1993) Chronic spinal infusion of dexmedetomidine, ST-91 and clonidine: spinal alpha 2 adrenoceptor subtypes and intrinsic activity. J Pharmacol Exp Ther 264: 327\u2013335.","DOI":"10.1016\/S0022-3565(25)10272-3"},{"key":"10.1124\/jpet.107.125526_bib34","doi-asserted-by":"crossref","unstructured":"Tallarida RJ (1992) Statistical analysis of drug combinations for synergism [published erratum appears in Pain 1993 Jun;53(3):365] Pain 49: 93\u201397.","DOI":"10.1016\/0304-3959(92)90193-F"},{"key":"10.1124\/jpet.107.125526_bib35","doi-asserted-by":"crossref","unstructured":"Tallarida RJ and Murray RB (1987) Manual of Pharmacological Calculations with Computer Programs pp 26\u201331, Springer Verlag, New York.","DOI":"10.1007\/978-1-4612-4974-0_9"},{"key":"10.1124\/jpet.107.125526_bib36","doi-asserted-by":"crossref","unstructured":"Walker SM, Goudas LC, Cousins MJ, and Carr DB (2002) Combination spinal analgesic chemotherapy: a systematic review. Anesth Analg 95: 674\u2013715.","DOI":"10.1213\/00000539-200209000-00033"},{"key":"10.1124\/jpet.107.125526_bib37","doi-asserted-by":"crossref","unstructured":"Wikberg-Matsson A, Wikberg JE, and Uhlen S (1995) Identification of drugs subtype-selective for alpha 2A-, alpha 2B-, and alpha 2C-adrenoceptors in the pig cerebellum and kidney cortex. Eur J Pharmacol 284: 271\u2013279.","DOI":"10.1016\/0014-2999(95)00354-N"},{"key":"10.1124\/jpet.107.125526_bib38","doi-asserted-by":"crossref","unstructured":"Wild KD, Press JB, and Raffa RB (1994) Alpha2-adrenoceptors: can subtypes mediate selective analgesia? Analgesia 1: 15\u201325.","DOI":"10.3727\/107156994819564384"},{"key":"10.1124\/jpet.107.125526_bib39","doi-asserted-by":"crossref","unstructured":"Yasuoka S and Yaksh TL (1983) Effects on nociceptive threshold and blood pressure of intrathecally administered morphine and alpha-adrenergic agonists. Neuropharmacology 22: 309\u2013315.","DOI":"10.1016\/0028-3908(83)90245-9"},{"key":"10.1124\/jpet.107.125526_bib40","doi-asserted-by":"crossref","unstructured":"Young P, Berge J, Chapman H, and Cawthorne MA (1989) Novel alpha 2-adrenoceptor antagonists show selectivity for alpha 2A- and alpha 2B-adrenoceptor subtypes. Eur J Pharmacol 168: 381\u2013386.","DOI":"10.1016\/0014-2999(89)90801-7"},{"key":"10.1124\/jpet.107.125526_bib41","doi-asserted-by":"crossref","unstructured":"Yu A and Frishman WH (1996) Imidazoline receptor agonist drugs: a new approach to the treatment of systemic hypertension. J Clin Pharmacol 36: 98\u2013111.","DOI":"10.1002\/j.1552-4604.1996.tb04174.x"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524341862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524341862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.107.125526","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:27:49Z","timestamp":1740004069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524341862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0022356524341862"],"URL":"https:\/\/doi.org\/10.1124\/jpet.107.125526","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ST91 [2-(2,6-Diethylphenylamino)-2-imidazoline Hydrochloride]-Mediated Spinal Antinociception and Synergy with Opioids Persists in the Absence of Functional \u03b1-2A- or \u03b1-2C-Adrenergic Receptors","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.107.125526","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}